Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome
Article first published online: 8 FEB 2007
Journal of Gastroenterology and Hepatology
Volume 22, Issue 3, pages 293–303, March 2007
How to Cite
Tarantino, G., Saldalamacchia, G., Conca, P. and Arena, A. (2007), Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome. Journal of Gastroenterology and Hepatology, 22: 293–303. doi: 10.1111/j.1440-1746.2007.04824.x
- Issue published online: 8 FEB 2007
- Article first published online: 8 FEB 2007
- Accepted for publication 24 October 2006.
- non-alcoholic fatty liver disease;
- non-alcoholic steatohepatitis;
- insulin resistance;
- metabolic syndrome;
Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidema, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.